title: Recombinant alpha-interferon and verruca plantaris. A review of the literature.
abstract: The authors review the literature and report the mechanisms of action, chemical properties, pharmacokinetics, adverse effects, and clinical studies of recombinant alpha-interferon. The authors believe that clinical trials should be performed with recombinant alpha-interferon therapy on verruca plantaris to prove or disprove the effectiveness of interferon as a potential treatment modality for these commonly encountered lesions.
authors.affiliation: College of Podiatric Medicine and Surgery, University of Osteopathic Medicine and Health Sciences, Des Moines, IA 50312.
authors.forename: R E
authors.initials: RE
authors.lastname: Johnson
authors.forename: J C
authors.initials: JC
authors.lastname: Johnson
authors.forename: S J
authors.initials: SJ
authors.lastname: Kloberdanz
authors.forename: M J
authors.initials: MJ
authors.lastname: Morrill
mesh_terms: D002986:Clinical Trials as Topic; D005534:Foot Diseases / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D011994:Recombinant Proteins; D014860:Warts / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins